GlycoMimetics (GLYC) is a clinical-stage drug developer aiming to create what’s called glycobiology-based therapies for cancers. This one has a catch, however. It’s a small biotech name. ...
GlycoMimetics (GLYC) is a clinical-stage drug developer aiming to create what’s called glycobiology-based therapies for cancers. This one has a catch, however. It’s a small biotech name. ...